Task: Please answer the following question about the molecule with SMILES CC(=O)N1CCC(NC(=O)NC23CC4CC(CC(C4)C2)C3)CC1.
Request: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Completion: Phase 2 Clinical Trials
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CC(=O)N1CCC(NC(=O)NC23CC4CC(CC(C4)C2)C3)CC1
CC(=O)N1CCC(NC(=O)NC23CC4CC(CC(C4)C2)C3)CC1
1-(1-acetylpiperidin-4-yl)-3-(1-adamantyl)urea
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.